Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

  1. Tilmont, R.
  2. Yakoub-Agha, I.
  3. Eikema, D.-J.
  4. Zinger, N.
  5. Haenel, M.
  6. Schaap, N.
  7. Arroyo, C.H.
  8. Schuermans, C.
  9. Besemer, B.
  10. Engelhardt, M.
  11. Kuball, J.
  12. Michieli, M.
  13. Schub, N.
  14. Wilson, K.M.O.
  15. Bourhis, J.H.
  16. Mateos, M.V.
  17. Rabin, N.
  18. Jost, E.
  19. Kröger, N.
  20. Moraleda, J.M.
  21. Za, T.
  22. Hayden, P.J.
  23. Beksac, M.
  24. Mclornan, D.
  25. Schönland, S.
  26. Manier, S.
  27. Montrer des auteurs +
Revue:
Bone Marrow Transplantation

ISSN: 1476-5365,  0268-3369

Année de publication: 2023

Volumen: 58

Número: 11

Pages: 1182-1188

Type: Article

DOI: 10.1038/S41409-023-02048-7 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus